These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 3390814)
1. Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors. Braunschweiger PG Cancer Res; 1988 Aug; 48(15):4206-10. PubMed ID: 3390814 [TBL] [Abstract][Full Text] [Related]
2. Effect of dexamethasone on vascular function in RIF-1 tumors. Braunschweiger PG; Schiffer LM Cancer Res; 1986 Jul; 46(7):3299-303. PubMed ID: 3708563 [TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors. Braunschweiger PG; Johnson CS; Kumar N; Ord V; Furmanski P Cancer Res; 1988 Nov; 48(21):6011-6. PubMed ID: 3262418 [TBL] [Abstract][Full Text] [Related]
4. Role of corticosteroid hormones in the control of cell proliferation in residual tumor after surgical cytoreduction. Braunschweiger PG; Ting HL; Schiffer LM Cancer Res; 1983 Dec; 43(12 Pt 1):5801-7. PubMed ID: 6640531 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic implications of cell kinetic changes after cyclophosphamide treatment in "spontaneous" and "transplantable" mammary tumors. Branunschweiger PG; Schiffer LM Cancer Treat Rep; 1978 May; 62(5):727-36. PubMed ID: 657158 [TBL] [Abstract][Full Text] [Related]
6. Cell kinetic-directed sequential chemotherapy with cyclophosphamide and adriamycin in T1699 mammary tumors. Braunschweiger PG; Schiffer LM Cancer Res; 1980 Mar; 40(3):737-43. PubMed ID: 7471093 [TBL] [Abstract][Full Text] [Related]
7. Effect of methylprednisolone on the cell kinetic response of C3H/HeJ mammary tumors to cyclophosphamide and adriamycin. Braunschweiger PG; Schiffer LM Cancer Res; 1979 Oct; 39(10):3812-5. PubMed ID: 476617 [TBL] [Abstract][Full Text] [Related]
8. Effect of adriamycin on the cell kinetics of 13762 rat mammary tumors and implications for therapy. Braunschweiger PG; Schiffer LM Cancer Treat Rep; 1980; 64(2-3):293-300. PubMed ID: 7407764 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Tozer GM; Prise VE; Wilson J; Cemazar M; Shan S; Dewhirst MW; Barber PR; Vojnovic B; Chaplin DJ Cancer Res; 2001 Sep; 61(17):6413-22. PubMed ID: 11522635 [TBL] [Abstract][Full Text] [Related]
10. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363 [TBL] [Abstract][Full Text] [Related]
11. Changes in growth rate of an experimental solid tumor following increasing doses of cyclophosphamide. Looney WB; Ritenour ER; Hopkins HA Cancer Res; 1980 Jul; 40(7):2179-83. PubMed ID: 7388785 [TBL] [Abstract][Full Text] [Related]
12. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow. Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982 [TBL] [Abstract][Full Text] [Related]
13. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633 [TBL] [Abstract][Full Text] [Related]
14. Anatomical and functional vascular changes in hamster cheek pouch during carcinogenesis induced by 7, 12-dimethylbenz(a)anthracene. Lurie AG; Tatematsu M; Nakatsuka T; Rippey RM; Ito N Cancer Res; 1983 Dec; 43(12 Pt 1):5986-94. PubMed ID: 6416672 [TBL] [Abstract][Full Text] [Related]
15. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988. Issekutz AC; Szpejda M Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199 [TBL] [Abstract][Full Text] [Related]
16. [Local blood flow and capillary permeability in the experimental meningeal carcinomatosis]. Yamada N; Yamada K; Ushio Y; Hayakawa T; Kato A; Mogami H No To Shinkei; 1984 Mar; 36(3):221-6. PubMed ID: 6588976 [TBL] [Abstract][Full Text] [Related]
17. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Henderson BW; Waldow SM; Mang TS; Potter WR; Malone PB; Dougherty TJ Cancer Res; 1985 Feb; 45(2):572-6. PubMed ID: 3967232 [TBL] [Abstract][Full Text] [Related]
18. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671 [TBL] [Abstract][Full Text] [Related]
19. Influence of a prostaglandin synthesis inhibitor and of thrombocytopenia on tumor blood flow and tumor vascular permeability. Experimental studies in the rat. Peterson HI; Alpsten M; Skolnik G; Karlsson L Anticancer Res; 1985; 5(3):253-7. PubMed ID: 4015039 [TBL] [Abstract][Full Text] [Related]
20. Acute in vivo resistance in high-dose therapy. Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]